Preview Mode Links will not work in preview mode

Apr 26, 2021

Dr. Martijn Wijburg discusses pharmacovigilance of patients treated with disease-modifying therapies for MS.

Show references:

https://pubmed.ncbi.nlm.nih.gov/33229453/